Betting against biotech is usually a dangerous game for retail investors -- add leverage and you're entering Crazytown. More
- ADVERTISEMENT
-
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
IBB
Recent Articles
This Top Sector Should Continue to Outperform
iShares Nasdaq Biotechnology (IBB) is trading within a powerful bull channel and just flashed a new buy signal. More
How to Profit From Every Biotech Buyout
Amgen's acquisition of Onyx underscores the fact that one simple biotech investment may also be the best one. More
Changing U.S. Demographics Mean a Decades-Long Healthcare Boom
The aging of America's boomers is a compelling macro trend at work. And there's no better way to play that trend than via these ETFs. More
The Best & Worst ETFs in 2013′s First Half
Some of the market's biggest headlines -- as well as a couple hidden stories -- are reflected in this list of the best and worst ETFs so far in 2013. More
5 ETFs Set to Soar in the Second Half of 2013
The best way to invest amid a cloudy outlook is longer-term and lower-risk. One of the easiest ways to take on that kind of strategy is to buy diversified ETFs. More
